Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Leifeng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8305-1900; OpenAlex author ID A5058925541. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2021: 3 papers · 2022: 2 papers · 2023: 2 papers · 2024: 2 papers · 2025: 2 papers

Papers 11

  1. The deubiquitylase OTUB1 drives gemcitabine resistance in pancreatic cancer by enhancing pyrimidine metabolism through modulating DHODH mRNA stability. Co-author DOI 10.1038/s41419-025-08001-4↗
  2. Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-025-10098-8↗
  3. Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment. Co-author DOI 10.1038/s41419-024-07048-z↗
  4. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Co-author DOI 10.1186/s13578-024-01213-9↗
  5. SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Last author DOI 10.1038/s41388-023-02843-y↗
  6. Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853. Co-author DOI 10.3390/ijms24097923↗
  7. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Co-author DOI 10.1038/s41419-022-04960-0↗
  8. TRIM16 promotes aerobic glycolysis and pancreatic cancer metastasis by modulating the NIK-SIX1 axis in a ligase-independent manner. Co-author PMID 36504902↗
  9. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα. Co-author DOI 10.1038/s41388-020-01527-1↗
  10. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. Co-author DOI 10.1038/s41419-021-04163-z↗
  11. RING-finger protein 6 enhances c-Myc-mediated Warburg effect by promoting MAD1 degradation to facilitate pancreatic cancer metastasis. Co-author PMID 34094667↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaogang Peng · 6 shared papers, 2021–2025 · strength 1.04
  2. Rongfa Yuan · 5 shared papers, 2021–2024 · strength 0.77
  3. Yunyan Du · 4 shared papers, 2021–2024 · strength 0.64
  4. Wenming Zhang · 3 shared papers, 2023–2025 · strength 0.62
  5. Chen Huan Luo · 2 shared papers, 2022–2024 · strength 0.34
  6. Jinfeng Zhu · 2 shared papers, 2022–2024 · strength 0.34
  7. Xueqiang Deng · 2 shared papers, 2021–2023 · strength 0.29
  8. Hengqing Zhu · 2 shared papers, 2021–2022 · strength 0.28
  9. Yumin Qiu · 2 shared papers, 2021–2022 · strength 0.28
  10. Fan Zhou · 1 shared paper, 2025 · strength 0.23
  11. Chaojie Zhai · 1 shared paper, 2025 · strength 0.23
  12. Jie He · 1 shared paper, 2023 · strength 0.22
  13. Fan Zhou · 1 shared paper, 2024 · strength 0.22
  14. Ying Huang · 1 shared paper, 2022 · strength 0.15
  15. Bin Zhou · 1 shared paper, 2022 · strength 0.15
  16. Ben Che · 1 shared paper, 2023 · strength 0.15
  17. Xin Yu · 1 shared paper, 2022 · strength 0.13
  18. Jiefeng Zhao · 1 shared paper, 2022 · strength 0.13
  19. Fanqin Bu · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.